By increasing production capacities of the company, taking care of environment protection with high responsibility and investing LVL 2.5 million, on the eve of the...
Grindeks was proposed by the pharmaceutical company “Instituto Biológico Argentino S.A.I.C.” (“BIOL”) for a joint international project “Oxytocin in Unijecttm” conducted by PATH*. Within the...
JSC Grindeks reports on information received on 5th and 6th February 2009 at Regional Offices of State Agency of Medicines of Russian Federation (hereinafter ROSZDRAVNADZOR)...
Today, on January 22, Riga, Krustpils Street 53, JSC Grindeks solemnly opened a new final dosage forms plant which is the most considerable investment project...
On December 3, in the ceremony The Baltic Market Awards, companies listed in the Nasdaq OMX Baltic Stock exchanges have been announced and awarded as...
Today, on October 10 – on the World Mental Health Day – JSC Grindeks organizes an international conference “Modern Ambulatory Health Care Methods in Psychiatry”....
From September 30 to October 2, JSC Grindeks will participate in the international exhibition „CPhI Worldwide 2008” in Frankfurt, Germany. In its exhibition stand Grindeks...
